Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Therapeutic Advances in Gastroenterology|July 15, 2021
Safety and efficacy of sodium picosulfate, magnesium oxide, and citric acid bowel preparation in patients with baseline renal impairment or diabetes: subanalysis of a randomized, controlled trialGautam N Mankaney, Masakazu Ando, David N Dahdal, et al.World Journal of Gastroenterology|November 12, 2020
Pediatric bowel preparation: Sodium picosulfate, magnesium oxide, citric acid <i>vs</i> polyethylene glycol, a randomized trialCarmen Cuffari, Steven L Ciciora, Masakazu Ando, et al.Therapeutic Advances in Gastroenterology|February 26, 2020
Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded studyLawrence Hookey, Gerald Bertiger, Kenneth Lee Johnson, et al.Therapeutic Advances in Gastroenterology|April 22, 2020
Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded studyLawrence Hookey, Gerald Bertiger, Kenneth Lee Johnson, et al.Open Forum Infectious Diseases|January 23, 2023
Microbiota-Based Live Biotherapeutic RBX2660 for the Reduction of Recurrent <i>Clostridioides difficile</i> Infection in Older Adults With Underlying ComorbiditiesGlenn Tillotson, Laurie Archbald-Pannone, Stuart Johnson, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 23, 2017
EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISMGlenn Cunningham, Laurence Belkoff, Gerald Brock, et al.Advances in Therapy|March 28, 2025
Healthcare Utilization and Costs of Care in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation After Initiating Oral Therapies: Real-World Analysis in the US Medicare PopulationEric Shah, Tsung-Ying Lee, Zachary Baldwin, et al.F&S Reports|July 5, 2021
Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trialJared C Robins, Andrew F Khair, Eric A Widra, et al.The Lancet. Gastroenterology & Hepatology|January 11, 2024
Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialCarlo Di Lorenzo, Julie Khlevner, Gerardo Rodriguez-Araujo, et al.Pageof 1